Full-Time
Advanced – Project Engineer
Multiple Teams
Brainlab
1,001-5,000 employees
Medical software and hardware for surgeries
No salary listed
Munich, Germany
Hybrid
 Biology & Biotech (1) |
|---|
- Degree in a technical or scientific field such as biomedical engineering, medical technology, mechanical engineering, electrical engineering, computer science, physics, or a comparable discipline.
- Experience in medical device development and familiarity with risk analysis or safety-related processes.
- Strong analytical mindset and ability to understand complex technical systems and their interactions.
- Interest in systems engineering and safety-driven product development.
- Structured working style with high standards for documentation quality.
- Strong communication skills and ability to collaborate in interdisciplinary teams.
- Curiosity and willingness to expand expertise in the field of medical device risk management.
- Affinity for hardware-related topics such as surgical platforms or instruments is a plus.
- Experience with risk management standards (e.g. ISO 14971) is beneficial.
- Fluent written and spoken English, German is a plus.
- Act as a central contact for risk-related topics within the Cranial Navigation R&D organization.
- Support development teams in identifying, analyzing, and mitigating risks throughout the medical device lifecycle.
- Contribute to the development and execution of risk management strategies for complex medical systems and their interfaces.
- Apply systems thinking to evaluate interactions between devices, accessories, clinical workflows, and users.
- Support human factors engineering bringing the risk management perspective.
- Support the creation, review, and maintenance of risk management documentation in accordance with regulatory requirements.
- Coordinate use case–driven risk analyses together with domain experts and use case owners.
- Drive the Polarion transition of Cranial Navigation risk management portfolio from concept to implementation together with domain and clinical experts.
- Provide consulting and guidance to development teams on risk analysis approaches and best practices.
- Review and support harmonize risk documentation across projects to ensure consistency and high quality standards.
- Collaborate with internal stakeholders across R&D, Quality Management, Regulatory Affairs, and Product Management.
- Contribute to cross-portfolio alignment of risk management topics with other Brainlab product areas.
- Support the continuous improvement of risk management structures, tools, and documentation processes.
- Support the maintenance of risk documentation for released products, including updates driven by Post Market Surveillance or compatibility changes.
- Contribute to ensuring compliance with relevant standards and regulations, including ISO 14971 and related frameworks.
- Medical device development and documentation on system level.
- Contribute to medical device development and system-level documentation within the Cranial Navigation product line.
- Experience with risk management standards (ISO 14971) is beneficial.
- Affinity for hardware-related topics such as surgical platforms or instruments is a plus.
- Fluent written and spoken English, German is a plus.
Brainlab is a medical technology company that creates software and hardware to improve surgeries, radiosurgery treatments, and operating room efficiency. It serves hospitals and clinics by providing digital tools that enhance surgical precision and patient outcomes. The core products include image-guided navigation, planning software, and connected hardware that work together to guide procedures. Revenue comes from selling software licenses, hardware devices, and ongoing subscription services that include updates and support. The company differentiates itself by offering integrated digital medical technologies that combine software and hardware for a seamless clinical workflow, backed by service agreements. Its goal is to help healthcare providers perform safer, more accurate procedures and run operating rooms more efficiently through data-driven tools and ongoing support.
Company Size
1,001-5,000
Company Stage
Early VC
Total Funding
$7.3M
Headquarters
Munich, Germany
Founded
1989
Simplify's Take
What believers are saying
- Lovell contract expands VA/DoD access to surgical tech in 2025.
- Record €239M H1 FY2024/25 revenue with 22.4% EBITDA margin.
- Partnership targets epilepsy, Parkinson's, Alzheimer's via PNM-201 drug.
What critics are saying
- Postponed €378M Frankfurt IPO blocks growth capital until 2026.
- Precision NeuroMed PNM-201 fails Phase 2/3 trials in 18-36 months.
- Stryker, Medtronic displace Brainlab with scaled AI navigation.
What makes Brainlab unique
- Brainlab pioneers AI-enabled CED platform with Precision NeuroMed for brain diseases.
- FDA-cleared Spine Mixed Reality Navigation enhances surgical precision uniquely.
- Integrated software-hardware boosts radiosurgery and OR efficiency globally.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Brainlab who can refer or advise you
Benefits
Remote Work Options
Flexible Work Hours
Paid Vacation
Paid Holidays
Conference Attendance Budget
Professional Development Budget
Wellness Program
Mental Health Support
Stock Options
Company Equity
401(k) Retirement Plan
401(k) Company Match
Phone/Internet Stipend
Home Office Stipend
Health Insurance
Company News
Brainlab and Precision NeuroMed have formed a strategic partnership to develop an AI-enabled treatment planning platform for convection enhanced delivery (CED) to the brain. Brainlab has taken an equity stake in the clinical-stage biotechnology company as part of the collaboration. The partnership aims to create a cloud-based CED Treatment Planning System that combines Brainlab's medical imaging expertise with Precision NeuroMed's molecular flow simulation software. The platform will use advanced imaging and AI-driven optimisation to personalise drug distribution, overcoming blood-brain barrier limitations that restrict most systemically administered drugs. Initial development will focus on supporting Precision NeuroMed's lead drug, PNM-201, for recurrent glioblastoma. The companies plan to expand the platform to enable delivery of therapies for epilepsy, Parkinson's disease, Alzheimer's disease and ALS.
Lovell Government Services, a Service-Disabled Veteran-Owned Small Business, has been awarded a Patient Monitoring and Capital Equipment contract with Brainlab, expanding access to advanced surgical technology across VA and DoD facilities. The partnership adds capital equipment and patient monitoring solutions to Lovell's federal portfolio, which previously focused on consumables. Brainlab, a digital medical technology company operating in 4,000 hospitals across 120 countries, first partnered with Lovell in 2024. The company develops integrated hardware and software for surgery and radiation therapy. The contract builds on Lovell's strong 2025 performance, which included over $100 million in sales, expanded Defence Logistics Agency Electronic Catalog access, and pharmaceutical distribution accreditation. Founded in 2013, Lovell has appeared four times on the Inc. 5000 list.
Brainlab has received FDA 510(k) clearance and launched its Spine Mixed Reality Navigation system in the United States.
Medtech firm Brainlab has decided to postpone its planned initial public offering (IPO) in Frankfurt, which was expected to raise $378 million.
Brainlab AG is launching an IPO on the Frankfurt Stock Exchange to raise up to €200 million, aiming to enhance its digital healthcare ecosystem. The company reported record revenues of €239 million and a 22.4% EBITDA margin in the first half of FY 2024/25. The IPO proceeds will support commercialization, expansion into new clinical applications, and balance sheet strengthening. Brainlab targets mid-term revenue growth of 10-13% and an EBITDA margin in the mid-20s, with a long-term goal of up to 30%.